HAP Trading, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$13
-99.9%
33,600
-13.4%
0.00%0.0%
Q3 2022$12,000
-72.7%
38,800
+256.0%
0.00%
-50.0%
Q2 2017$44,000
-63.9%
10,900
-1.8%
0.00%
-50.0%
Q3 2016$122,000
+248.6%
11,100
-82.9%
0.00%
+100.0%
Q2 2016$35,00064,8000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders